ArticleThe oncologist2025

Management of severe immune-related adverse events and outcomes in patients with advanced non-small cell lung cancer receiving immune checkpoint inhibitors.

Jarushka Naidoo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.